Nosocomial Plasmodium falciparum infections confirmed by molecular typing in Medellin, Colombia

dc.creatorRestrepo Pineda, Eliana
dc.creatorBlair Trujillo, Silvia
dc.creatorMaestre Buitrago, Amanda Elena
dc.creatorGonzález, Lina
dc.creatorOchoa, Jesús
dc.creatorFranco Hincapié, Liliana
dc.creatorArroyave, Marta
dc.date2023-04-27T15:50:07Z
dc.date2023-04-27T15:50:07Z
dc.date2005
dc.date.accessioned2024-04-23T14:15:16Z
dc.date.available2024-04-23T14:15:16Z
dc.identifierGonzález L, Ochoa J, Franco L, Arroyave M, Restrepo E, Blair S, Maestre A. Nosocomial Plasmodium falciparum infections confirmed by molecular typing in Medellín, Colombia. Malar J. 2005 Feb 9;4:9. doi: 10.1186/1475-2875-4-9.
dc.identifier1475-2875
dc.identifierhttps://hdl.handle.net/10495/34770
dc.identifier10.1186/1475-2875-4-9
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/9229364
dc.descriptionABSTRACT: Three cases of nosocomial malaria are reported from patients of the Internal Medicine Ward of a tertiary University teaching hospital in Medellin, Colombia. Epidemiological research, based on entomological captures, medical records review and interviews of nursery staff about patient care practices potentially involving contact with blood, were carried out. Molecular characterization of Plasmodium falciparum was based on the amplification of MSP1, MSP2 and GLURP genes. This method enabled confirmation of the same P. falciparum genotype in all three patients as well as in a fourth one (index case). The presence of nosocomial malaria was confirmed and it was concluded that the most likely source of transmission was through multi-dose preparations of heparin applied to heparin locks.
dc.descriptionCOL0047449
dc.descriptionCOL0007524
dc.format5
dc.formatapplication/pdf
dc.formatapplication/pdf
dc.languageeng
dc.publisherBMC (BioMed Central)
dc.publisherGrupo Malaria
dc.publisherSalud y Comunidad
dc.publisherLondres, Inglaterra
dc.relationMalar. J.
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightshttp://creativecommons.org/licenses/by/2.5/co/
dc.rightshttp://purl.org/coar/access_right/c_abf2
dc.rightshttps://creativecommons.org/licenses/by/4.0/
dc.subjectAntígenos de Protozoos - genética
dc.subjectAntigens, Protozoan - genetics
dc.subjectColombia - epidemiología
dc.subjectColombia - epidemiology
dc.subjectInfección Hospitalaria
dc.subjectCross Infection
dc.subjectCombinación de Medicamentos
dc.subjectDrug Combinations
dc.subjectContaminación de Equipos
dc.subjectEquipment Contamination
dc.subjectResultado Fatal
dc.subjectFatal Outcome
dc.subjectMalaria Falciparum
dc.subjectMalaria, Falciparum
dc.subjectPlasmodium falciparum
dc.subjectProteína 1 de Superficie de Merozoito - genética
dc.subjectMerozoite Surface Protein 1 - genetics
dc.subjectReacción en Cadena de la Polimerasa - métodos
dc.subjectPolymerase Chain Reaction - methods
dc.subjectProteínas Protozoarias - génetica
dc.subjectProtozoan Proteins - genetics
dc.subjectPirimetamina - uso terapéutico
dc.subjectPyrimethamine - therapeutic use
dc.subjectQuinina - uso terapéutico
dc.subjectQuinine - therapeutic use
dc.subjectSulfadoxina - uso terapéutico
dc.subjectSulfadoxine - therapeutic use
dc.titleNosocomial Plasmodium falciparum infections confirmed by molecular typing in Medellin, Colombia
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typehttp://purl.org/coar/resource_type/c_6501
dc.typehttps://purl.org/redcol/resource_type/ARTCASO
dc.typeReporte de caso


Este ítem pertenece a la siguiente institución